Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Oct 1;49(10):e1057-e1058.
doi: 10.1097/CCM.0000000000005103.

Bivalirudin Superior to Heparin for Extracorporeal Membrane Oxygenation: Not So Fast

Michael A Mazzeffi  1 , Michael Plazak  2 , Heidi Dalton  3
Affiliations
Comment

Bivalirudin Superior to Heparin for Extracorporeal Membrane Oxygenation: Not So Fast

Michael A Mazzeffi et al. Crit Care Med. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Dr. Plazak disclosed the off-label product use of Bivalirudin and heparin for the maintenance of extracorporeal membrane oxygenation (ECMO) circuit integrity. Dr. Dalton received funding from Innovative ECMO concepts, Abiomed/Breethe Oxi 1, and Entegrion viscoelastic coagulation monitor; she disclosed the off-label product use of ECMO. Dr. Mazzeffi disclosed that he does not have any potential conflicts of interest.

Comment in

  • The authors reply.
    Rivosecchi RM, Sanchez PG. Rivosecchi RM, et al. Crit Care Med. 2021 Oct 1;49(10):e1059-e1060. doi: 10.1097/CCM.0000000000005236. Crit Care Med. 2021. PMID: 34529630 No abstract available.

Comment on

References

    1. Rivosecchi RM, Arakelians AR, Ryan J, Murray H, et al.: Comparison of anticoagulation strategies in patients requiring venovenous extracorporeal membrane oxygenation: Heparin versus bivalirudin. Crit Care Med. 2021; 49:1129–1136
    1. Kaseer H, Soto-Arenall M, Sanghavi D, et al.: Heparin vs bivalirudin anticoagulation for extracorporeal membrane oxygenation. J Card Surg. 2020; 35:779–786
    1. Nilsson KR, Berenholtz SM, Garrett-Mayer E, et al.: Association between venous thromboembolism and perioperative allogeneic transfusion. Arch Surg. 2007; 142:126–132; discussion 133
    1. Vera-Aguilera J, Yousef H, Beltran-Melgarejo D, et al.: Clinical scenarios for discordant anti-Xa. Adv Hematol. 2016; 2016:4054806
    1. Potze W, Arshad F, Adelmeijer J, et al.: Routine coagulation assays underestimate levels of antithrombin-dependent drugs but not of direct anticoagulant drugs in plasma from patients with cirrhosis. Br J Haematol. 2013; 163:666–673